Emergence of Drug Resistance in Human Immunodeficiency Virus Type 1 Infected Patients from Pune, India, at the End of 12 Months of First Line Antiretroviral Therapy Initiation
ISRN AIDS · 2014
DOI: 10.1155/2014/674906 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN AIDS, 2014. Verfasst von Rajesh T Patil und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Azeezia Institute of Medical Sciences & Research, Kollam, Kerala, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Introduction
In India, 4,86,173 HIV infected patients are on first line antiretroviral therapy (ART) as of January 2012. HIV drug resistance (HIVDR) is drug and regimen-specific and should be balanced against the benefits of providing a given ART regimen. Material & Methods. The emergence of HIVDR mutations in a cohort of 100 consecutive HIV-1 infected individuals attending ART centre, on first line ART for 12 months, was studied. CD4 + T-cell counts and plasma HIV-1 RNA level were determined.
Result
Out of the 100 HIV-1 infected individuals, 81 showed HIVDR prevention (HIV-1 RNA level < 1000/mL), while the remaining 19 had HIV-1 viral RNA level > 1000/mL. HIVDR genotyping was carried out for individuals with evidence of virologic failure (HIV-1 RNA level > 1000/mL). The most frequent NRTI-associated mutation observed was M184V, while K103N/S was the commonest mutation at NNRTI resistance position.
Conclusion
Our study has revealed the emergence of HIVDR in HIV-1 infected patients at the end of 12 months of first line ART initiation. For NRTIs, the prevalence of HIVDR mutations was 9% and 10% for NNRTIs. Our findings will contribute information in evidence-based decision making with reference to first and second line ART delivery and prevention of HIVDR emergence.
Autor:innen und Institutionen
- Department of Microbiology, Azeezia Institute of Medical Sciences & Research, Kollam, Kerala, India.
- DDGMS (IT) Office of Directorate General of Medical Services (Army) Integrated HQ of MoDAG's Branch, L Block, New Delhi, India.
- Department of Microbiology, Army Hospital (Research & Referral), Delhi, India.
- National JALMA Institute of Leprosy and other Mycobacterial Diseases (Indian Council of Medical Research), Agra, India.
- National AIDS Research Institute (Indian Council of Medical Research), Pune, India.
ORCID-Profile: Sourav Sen
Zitieren
APA
Patil, R. T., Gupta, R. M., Sen, S., Tripathy, S. P., Chaturbhuj, D. N., Hingankar, N. K., & Paranjape, R. S. (2014). Emergence of Drug Resistance in Human Immunodeficiency Virus Type 1 Infected Patients from Pune, India, at the End of 12 Months of First Line Antiretroviral Therapy Initiation. ISRN AIDS. https://doi.org/10.1155/2014/674906
Vancouver
Patil RT, Gupta RM, Sen S, Tripathy SP, Chaturbhuj DN, Hingankar NK, et al. Emergence of Drug Resistance in Human Immunodeficiency Virus Type 1 Infected Patients from Pune, India, at the End of 12 Months of First Line Antiretroviral Therapy Initiation. ISRN AIDS. 2014. doi:10.1155/2014/674906
BibTeX
@article{Patil2014,
author = {Patil, Rajesh T and Gupta, Rajiv M and Sen, Sourav and Tripathy, Srikanth P and Chaturbhuj, Devidas N and Hingankar, Nitin K and Paranjape, Ramesh S},
title = {Emergence of Drug Resistance in Human Immunodeficiency Virus Type 1 Infected Patients from Pune, India, at the End of 12 Months of First Line Antiretroviral Therapy Initiation},
journal = {ISRN AIDS},
year = {2014},
doi = {10.1155/2014/674906}
}
EUVIMED